AD (Alzheimer's disease) is an age-associated neurodegenerative disorder where the accumulation of neurotoxic Aβ (amyloid β-peptide) in senile plaques is a typical feature. Recent studies point out a relationship between Aβ neurotoxicity and Ca 2+ dyshomoeostasis, but the molecular mechanisms involved are still under discussion. The PMCAs (plasma membrane Ca 2+ -ATPases) are a multi-isoform family of proteins highly expressed in brain that is implicated in the maintenance of low intraneural Ca 2+ concentration.
Introduction
AD (Alzheimer's disease) is one of the most common dementias worldwide associated with aging. It is characterized by a progressive loss of cognitive abilities and severe neurodegeneration, with amyloid plaque formation being one of the two hallmark lesions, together with neurofibrillary tangles of hyperphosphorylated tau. However, evidence for a correlation between an impairment of intracellular Ca 2+ signalling in neurons and the degeneration observed in AD has grown in the last few years. This is in line with the searching of molecular mechanisms involved in the disease rather than descriptive analysis of the pathological changes that occurs in the aging brain. The present mini-review is focused on the link between Ca 2+ ions and AD, the functional alteration of a key regulator of neural Ca 2+ homoeostasis, such as the PMCAs (plasma membrane Ca 2+ -ATPases), and its correlation with Aβ (amyloid β-peptide) and the lipid environment.
Calcium and AD
Neural cells contain many Ca 2+ -regulatory proteins that keep intracellular free Ca 2+ concentrations in the nanomolar range despite the millimolar concentration found in the extracellular space [1] . This feature allows cells to use transient waves of Ca 2+ ions as signalling messengers for the integration of many cellular functions, such as neurotransmitter release, Key words: aging, Alzheimer's disease, cholesterol, lipid raft, neurodegeneration, plasma membrane Ca 2+ -ATPase (PMCA). Abbreviations used: Aβ, amyloid β-peptide; AD, Alzheimer's disease; APP, amyloid precursor protein; PMCA, plasma membrane Ca 2+ -ATPase; SERCA, sarcoplasmic/endoplasmic reticulum Ca 2+ -ATPase. 1 To whom correspondence should be addressed (email anam@unex.es).
gene expression or neural plasticity [2] . However, failure of excitable cells to maintain optimum Ca 2+ cytosolic levels may well be a common pathway leading to cell death. This is critical in many aging processes, including neuronal dysfunction underlying dementia, giving rise to the Ca 2+ hypothesis of brain aging [3, 4] . In AD, Ca 2+ dysregulation seems to be highly influenced by the presence of neurotoxic Aβ in brains [5] . Different theories have been proposed in this respect, e.g. the formation of Ca 2+ channels by Aβ in the plasma membrane causing the entry of Ca 2+ into the cell [6] , or the induction of oxidative stress [7, 8] , which causes disruption of Ca 2+ homoeostasis and ends in apoptosis. In addition, Aβ may interact with Ca 2+ -regulatory proteins. Among all of the molecular systems involved in Ca 2+ regulation, the PMCAs are high-affinity active transporters that pump Ca 2+ ions out of the cells. They are members of the P-type ATPase family, which transport 1 mol of Ca 2+ driven by the hydrolysis of 1 mol of ATP, and are characterized by a regulatory C-terminal tail. For instance, the interaction of the pump with calmodulin produces a major enhancement of their activity (reviewed in [9]). Their high affinity for Ca 2+ (K a ≈100 nM [10] ) and the high expression of PMCA isoforms in nervous tissue [11] [12] [13] suggest that these Ca 2+ pumps are major contributors to neural Ca 2+ homoeostasis, participating in many processes from development to aging (reviewed in [14] ).
Altered Ca 2+ -dependence of PMCA in AD and its correlation with Aβ
The PMCA pump is functionally affected in AD with respect to Ca 2+ -dependence [15] . Thus, whereas in age-matched control human brains, PMCA showed the typical bell-shaped Ca 2+ -dependent ATPase activity with maximum stimulation at 3.16 μM free Ca 2+ , in AD-affected brains, PMCA showed the same activity in the range 0.316-31.6 μM free Ca 2+ . This effect could be reproduced when Aβ was added to PMCA purified from pig brain as well as to control human brain membranes, pointing out that the enrichment of toxic Aβ in AD-affected brains could be responsible for the altered function of PMCA.
In contrast, the activities of SERCA (sarcoplasmic/endoplasmic reticulum Ca 2+ -ATPase) and SPCA (secretory pathway Ca 2+ -ATPase) showed the standard Ca 2+ -dependence in AD-affected brains [15] , even though Aβ has been also detected in both compartments [16] . However, studies performed in cell lines have revealed a role for SERCA activity in Aβ production regulated by presenilins [17] . These proteins are also located in the endoplasmic reticulum. Several presenilin mutations have been related to early-onset AD, which seems to be involved in altered cleavage of APP (amyloid precursor protein) to generate toxic Aβ [18] . Thus presenilins could affect Ca 2+ signalling in AD via SERCA pump regulation.
The cerebellum is a less vulnerable region in AD [19] and showed no changes in the Ca 2+ -dependence of any Ca 2+ pumps, even when Aβ was added to cerebellar membranes [15] . This can be explained because the cerebellum only contains modest amounts of senile amyloid plaques (Figure 1 ). These differences were observed among brain regions and could be explained by a different composition in PMCA isoforms. Four different genes have been described (ATP2B1-ATP2B4) that encode four PMCA isoforms (PMCA1-PMCA4), and can be alternatively spliced in over 20 variants (reviewed in [20, 21] ). Several studies in different species have shown that PMCA4 is enriched in cerebral cortex, whereas high levels of PMCA2 are found in cerebellum, especially in Purkinje cells [11, 13, 22] . Thus the Aβ-mediated neurotoxicity seems to be PMCA-isoform-dependent, as was corroborated in assays with HEK (human embryonic kidney)-293 cell membranes overexpressing different PMCA isoforms, in which the brain-enriched PMCA4 showed the highest ATPase inhibition by Aβ [15] .
A protective effect of cholesterol on PMCA dysfunction
Additionally to brain-specific localization, different PMCA isoforms can be selectively distributed in specific membrane environments [23] . This may be related to differential kinetic properties and physiological roles. Thus, in synaptosomal plasma membranes, it has been shown that PMCA4 is the unique isoform located in lipid rafts [23] . These membrane microdomains are characterized by their abundance in cholesterol and glycosphingolipids and participate as platforms for cell signal transduction [24] [25] [26] . Thus disruption of lipid rafts can result in reduction of synapses and loss of dendritic spines, among other neurodegenerative processes [27] , unravelling its involvement in several pathologies such as prion diseases, cerebellar ataxia or AD [28, 29] . Lipid rafts have been described as preferential sites of cleavage of APP, leading to the formation of the neurotoxic Aβ [16, 30, 31] . This suggests that membrane lipid composition can be important for disease development. We have shown that the toxic effect of Aβ on PMCA activity The three membrane fractions were prepared using the procedure described in [23] . The Ca 2+ -ATPase activity was measured in the absence or presence of 2.5 μM Aβ 1-40 peptide. The 100% activity corresponds to PMCA activity of 0.16 ± 0.01, 0.03 ± 0.01 and 0.04 ± 0.01 μmol·min − 1 ·mg − 1 in Syn, Rafts and Non-rafts respectively.
can be prevented by cholesterol [15] . In fact, the PMCA activity found in synaptosomal raft domains, which contains the Aβ-sensitive PMCA4 isoform [23] , was not inhibited by Aβ (Figure 2 ). Therefore the lack of PMCA4 inhibition by the peptide seems to be due to the abundance of endogenous cholesterol in those lipid microdomains. This cholesterol protection against Aβ-mediated PMCA inhibition could be blocked by high concentrations of peptide [15] . According to this feature, a decrease in cholesterol concentration and increased density of gangliosides have been found in lipid rafts isolated from AD-affected brains [32] . Besides, the proportion of lipid rafts was decreased with respect to controls, and was correlated with the regional progression of the disease. Thus changes in neural membrane composition may gradually lead to raft disruption and dysfunction of proteins such as PMCA, affecting cellular signalling where such membrane domains are involved, and accelerating the progression of AD.
Concluding remarks
The observations described above propose PMCA as a functional component of the molecular mechanism involved in AD by its interaction with Aβ. Future investigation of the possible interaction with tau proteins, the other hallmark of AD, by association with scaffolding proteins from the plasma membrane will give us more data about the specific role of PMCA in AD. On the other hand, the role of cholesterol in neural membranes as modulator of protein function opens novel therapeutic perspectives in lipid-raftassociated diseases. 
